The state Board of Pharmacy sought to limit access to a powerful antioxidant. When firefighters and their allies — including those from Sonoma County — pushed back, state regulators blinked.
Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.
Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...
PA Groundhogs and the Center for Forensic Science Research & Education monitor for novel and emerging substances by testing ...
Clinical symptoms and signs are a bridge between biomedicine and traditional medicine [TM]. These can be associated with diseases incl. their diagnosis, pharmacological targets, and the use of ...
Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...
Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...
Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...
The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results